Diagnostics (Nov 2022)

D-dimer Testing in Pulmonary Embolism with a Focus on Potential Pitfalls: A Narrative Review

  • Loris Wauthier,
  • Julien Favresse,
  • Michaël Hardy,
  • Jonathan Douxfils,
  • Grégoire Le Gal,
  • Pierre-Marie Roy,
  • Nick van Es,
  • Cihan Ay,
  • Hugo ten Cate,
  • Thierry Vander Borght,
  • Michaël V. Dupont,
  • Thomas Lecompte,
  • Giuseppe Lippi,
  • François Mullier

DOI
https://doi.org/10.3390/diagnostics12112770
Journal volume & issue
Vol. 12, no. 11
p. 2770

Abstract

Read online

D-dimer is a multifaceted biomarker of concomitant activation of coagulation and fibrinolysis, which is routinely used for ruling out pulmonary embolism (PE) and/or deep vein thrombosis (DVT) combined with a clinical pretest probability assessment. The intended use of the tests depends largely on the assay used, and local guidance should be applied. D-dimer testing may suffer from diagnostic errors occurring throughout the pre-analytical, analytical, and post-analytical phases of the testing process. This review aims to provide an overview of D-dimer testing and its value in diagnosing PE and discusses the variables that may impact the quality of its laboratory assessment.

Keywords